batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASCO 2024 preview – first look at Kelun’s registrational TROP2 dataset 23 May 2024 Vizimpro delivers for Pfizer 21 May 2024 Pivotal Merck/Kelun TROP2 studies seek nearly 10,000 patients 21 May 2024 A second dato-dxd/Tagrisso combo 17 May 2024 US knocks back another Chinese PD-1 entrant 17 May 2024 ESMO Breast Cancer 2024 – Arvinas rises as vepdegestrant stays the same 16 May 2024 Astra holds its own in stage III lung cancer 13 May 2024 Gilead and Arcellx Immagine the future 10 May 2024 Load More